What to Know About MA Plans Formularies vary: Not all MA plans have added Zepbound for OSA to their formulary Prior authorization required: Nearly all plans require PA with sleep study documentation Cost sharing varies: Plans have different tiers, copays, and coinsurance 2026 out-of-pocket limits: In-network maximum is $9,250 (down from $9,350 in 2025) [5] Open Enrollment Consideration If your current Medicare plan doesn't cover Zepbound for OSA, you may be able to switch to a plan that does during the Annual Enrollment Period (October 15 - December 7) or Medicare Advantage Open Enrollment (January 1 - March 31)
Reduced appetite while therapeutically intended, this can occasionally lead to inadequate nutritional intake Injection site reactions mild redness, bruising, or discomfort at the site of subcutaneous injection Fatigue and dizziness reported in a subset of trial participants, often associated with early treatment phases Hypoglycaemia (low blood sugar) uncommon with retatrutide alone, but the risk increases when it is used alongside insulin or sulfonylureas
Any new or worsening symptoms after starting tirzepatide or adding new medications or supplements
When the product itself is unreliable, adverse event data becomes meaningless for understanding the actual drug safety profile
